Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer

Summary

This phase II trial is studying how well vorinostat works in treating patients with progressive metastatic prostate cancer. Drugs used in chemotherapy, such as vorinostat, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Vorinostat may also stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2006-03

Primary completion

2009-09

Completion

2011-05

Drugs

Indications